In this patient, the diagnosis of de novo AML with mutated NPM1 was made on his first bone marrow biopsy showing 70% CD13, CD33, CD117, HLA-DR(+), and CD34(−) myeloblasts with circulating blasts and marked leukocytosis. Here, CD33 is linked to acute myeloid leukemia.